Artificial Intelligence (AI) in the Breast Imaging Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Artificial Intelligence (AI) in Breast Imaging Market Size, Share & Trends Analysis Report By End-Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics & Trauma Centers), Region, Market Outlook And Industry Analysis 2031”
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1906
The Global Artificial Intelligence (AI) In Breast Imaging Market is estimated to reach over USD 3579.52 million by 2031, exhibiting a CAGR of 28.95% during the forecast period.
Data from breast imaging can be quantitatively analyzed using AI, including determining tumor size, analyzing lesion features, and monitoring changes over time. This data can help with patient outcome prediction, therapy response monitoring, and treatment planning. The adoption of AI algorithms has been made easier by the switch from conventional film-based imaging to digital imaging modalities such as digital mammography, ultrasound, and MRI. Large amounts of image data can be easily captured, stored, and analyzed thanks to digital imaging, which enables AI systems to gain knowledge from many datasets and enhance their performance.
The potential of AI in healthcare has been acknowledged by regulatory authorities, such as the U.S. Food and Drug Administration (FDA), which has established standards for the creation and use of AI-based medical devices. A framework for the implementation of AI in breast imaging is provided by clear regulations and guidelines, which also help to promote innovation and guarantee patient safety.
List of Prominent Players in the Artificial Intelligence (AI) in Breast Imaging Market:
• GE Healthcare
• Hologic, Inc.
• Gamma Medica, Inc.
• Siemens Healthcare
• Fujifilm Holdings Corp.
• Toshiba Corporation
• Aurora Imaging Technology, Inc.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
Market Dynamics:
Drivers-
The prevalence of breast cancer is increasing, healthcare costs are increasing, and this industry’s outlook is primarily being boosted by technology improvements. In addition, growing consumer demand for early disease diagnosis and treatment is opening up significant business potential for this industry. Additionally, the expansion of the aging population, the rising healthcare IT sector, and the rise in the female population are all accelerating the development of this industry vertical. There are more government initiatives to increase the rate of screening and diagnosis as cancer prevalence rises. The increased prevalence of breast cancer is expected to be the main driver of the market for artificial intelligence in breast imaging.
Challenges:
AI implementation in breast imaging can be expensive because of the high hardware and software costs. Adoption may be hampered by this, especially for smaller healthcare organizations or those working in environments with few resources. As more people survive cancer, the price of life-saving treatments also increases. Additionally, differences in imaging procedures, data privacy issues, and restricted data sharing can impede the creation and effectiveness of AI models. Regulation and legal issues are brought up by the use of AI-based medical devices in breast imaging.
Regional Trends:
The North America Artificial Intelligence (AI) in Breast Imaging Market is expected to register a major market share in terms of revenue and is projected to grow at a high CAGR in the near future. The high incidence of breast cancer, sophisticated healthcare infrastructure, robust research and development efforts, and rising investments in AI technologies are some of the variables that influence market size. Because AI is being used in more breast imaging applications, the market is predicted to expand further. The adoption of AI in healthcare is significantly influenced by the regulatory environment in North America, notably in the United States. The U.S. Food and Drug Administration (FDA) has offered recommendations for the creation and use of medical devices based on AI, including those used for breast imaging. The incorporation of AI technologies into clinical practice is made possible by clear norms and guidelines, which also encourage innovation.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1906
Recent Developments:
• In March 2022, The National Oncology Centre of Singapore (NCCS) and GE Healthcare announced to work jointly. This cooperation intends to promote the prospect of more individualized cancer treatment options and give patients a chance to review clinically significant information throughout the patient journey by applying artificial intelligence and language processing.
Segmentation of Artificial Intelligence (AI) in Breast Imaging Market-
By End-Use-
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics & Trauma Centers
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/1906
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: http://www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
